Related Experiment Video
Updated: Dec 31, 2025
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Abstract:
Although sporadic human infection due to Burkholderia cepacia has been reported for many years, it has been only during the past few decades that species within the B. cepacia complex have emerged as significant opportunistic human pathogens. Individuals with cystic fibrosis, the most common inherited genetic disease in Caucasian populations, or chronic granulomatous disease, a primary immunodeficiency, are particularly at risk of life-threatening infection. Despite advances in our understanding of the taxonomy, microbiology, and epidemiology of B. cepacia complex, much remains unknown regarding specific human virulence factors. The broad-spectrum antimicrobial resistance demonstrated by most strains limits current therapy of infection. Recent research efforts are aimed at a better appreciation of the pathogenesis of human infection and the development of novel therapeutic and prophylactic strategies.
Insights
Burkholderia cepacia complex infections are a growing threat, especially for individuals with cystic fibrosis or chronic granulomatous disease. Research is focusing on understanding virulence and developing new treatments for this antimicrobial-resistant bacteria.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Bacteriology
Background:
- Sporadic human infections with Burkholderia cepacia have been documented for years.
- In recent decades, B. cepacia complex species have increasingly emerged as significant opportunistic human pathogens.
- Individuals with cystic fibrosis and chronic granulomatous disease are at high risk for severe B. cepacia complex infections.
Purpose of the Study:
- To review the current understanding of Burkholderia cepacia complex as a human pathogen.
- To highlight knowledge gaps in B. cepacia complex virulence factors and pathogenesis.
- To discuss the challenges posed by antimicrobial resistance and the need for novel therapeutic strategies.
Main Methods:
- Review of existing literature on Burkholderia cepacia complex taxonomy, microbiology, epidemiology, and clinical significance.
- Analysis of antimicrobial resistance patterns.
- Discussion of current research trends in pathogenesis and treatment development.
Main Results:
- Burkholderia cepacia complex is an emerging opportunistic pathogen, particularly in immunocompromised individuals.
- Most strains exhibit broad-spectrum antimicrobial resistance, complicating treatment options.
- Specific human virulence factors remain largely uncharacterized.
Conclusions:
- Further research is crucial to elucidate the pathogenesis of B. cepacia complex infections.
- Development of novel therapeutic and prophylactic strategies is urgently needed to combat these infections.
- Understanding virulence factors is key to improving patient outcomes.
More Related Videos
Related Concept Videos
01:29Bacterial Phylum Chlamydiae
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...